Ribas-Fitó N, Ramón R, Ballester F, Grimalt J, Marco A, Olea N, Posada M, Rebagliato M, Tardón A, Torrent M, Sunyer J on behalf of the INMA Study Group. Child health and the environment: the INMA Spanish study. Paediatric and Perinatal Epidemiology 2006; 20: 403-410. The INMA (INfancia y Medio Ambiente [Environment and Childhood]) is a population-based cohort study in different Spanish cities, that focuses on prenatal environmental exposures and growth, development and health from early fetal life until childhood. The study focuses on five primary areas of research: (1) growth and physical development; (2) behavioural and cognitive development; (3) asthma and allergies; (4) sexual and reproductive development; and (5) environmental exposure pathways. The general aims of the project are:
Genetic factors and nutritional, environmental and psychosocial exposures in the prenatal and postnatal periods will be evaluated. Outcomes will include prenatal and birth health events, growth, neurodevelopment, behavioural functioning, immunity and endocrine disruption. The results of these studies will become available within the next few years, and will help to assess pregnant women and childhood exposure as well as other health determinants in several areas of Spain and its immediate and later impacts on human health.
Rationale
The physical, social and intellectual development of children from conception to the end of adolescence requires an environment that is both protected and protective of their health. A growing number of diseases in children are linked to unsafe environments. Prenatal and early life exposures, including diet, are associated with child health and human development and predispose to late adult effects. Thus, the INMA project is based on three main rationales.
First, exposure to environmental pollutants through air, water and food is worldwide. Children are especially vulnerable to its effects as they are not just little adults, they are still growing, and their immune system and detoxification mechanisms are not fully developed. Children are then more vulnerable than adults to environmental exposures. Persistent pollutants like organochlorine compounds (OC) and some metals have been related to impaired intrauterine growth, prematurity, postnatal growth and neurodevelopment and minor behavioural disorders. [1] [2] [3] [4] [5] Air pollutants e.g. particulates have been associated with infant mortality and with child health problems such as asthma and allergies. 6, 7 Less epidemiological evidence exists about fetal damage, especially fetal growth, and there is a need for further evidence. 8 Also, chemical products in the water, namely disinfection by-products, have been associated with reproductive and child health outcomes; 9,10 this warrants further research to establish the validity of the fundings and, if so, develop effective preventive strategies. Little is known about the individual susceptibility to certain chemicals, and further studies integrating gene-environment interactions are needed.
Second, there is growing evidence of the importance of nutrition during pregnancy and the first months of life on fetal and infant growth and development, as well as on lifelong health and well-being. Specifically, intake of essential fatty acids (omega 3, omega 6) during pregnancy and early postnatal life is involved in fetal and infant growth, neurodevelopment and visual function. 11, 12 Fish intake and supplementation with fish oil during pregnancy has also been associated with better postnatal neurodevelopment. [13] [14] [15] Moreover, low plasma levels of antioxidants and oxidative stress have been involved in pre-eclampsia and intrauterine growth retardation, [16] [17] [18] and it has been suggested that antioxidants in children have a protective influence on the risk of asthma. 19, 20 Third, some pollutants and nutrients have the same ingestion route. Fish, the principal source of omega 3, is also carrier of OCs and methyl-mercury. Breast feeding, the sole form of nutrition during the first month of life among breast feeders, carries both nutrients and pollutants. Although the mechanisms of toxicity for OCs are not well understood, the suggested underlying metabolic and hormonal mechanisms in neurotoxicity are also in the pathway of clinical effects due to deficiency of some essential fatty acids. 21, 22 It remains to be elucidated whether nutrients can counteract the pollutants' negative effects on health.
To characterise individual exposure levels during pregnancy and childhood, to identify the role of diet and other associated risk factors on reproductive outcomes and child health, and to understand the interactions between multiple factors and susceptibility will contribute to early identification of environmental risks and to the development of protective and preventive strategies.
Aims
The general aims of the project are: 
Design

Overview
The INMA Study is a prospective population-based cohort study concerned with the effects of pre-and postnatal environmental exposures on growth, development and health from early fetal life until young adulthood.
Investigations are carried out in pregnant women and children. Pregnant women are assessed at 12, 20 and 32 weeks of gestation to collect information about environmental exposures and fetal growth. Children will be assessed at birth, at the age of 1 year and at the age of 4 years.
Study cohorts (Table 1)
The INMA is based on experience acquired by groups studying the cohorts of Ribera d'Ebre ( n = 102), which evaluated the relation between organochlorines and methyl-mercury exposure and neurological development, Menorca ( n = 482), which studied the relation between allergy, development and asthma with air pollution, and Granada ( n = 668), which studied the incidence of infant reproductive health disorders in relation to potential environmental exposures.
Based on experience from these previous studies, a new research protocol was developed based on the work of different working groups: exposures, effects and design. The new cohorts have been designed to evaluate the impact of environmental exposures and diet on children's health: Valencia ( n = 1000), Sabadell ( n = 800), Asturias ( n = 500), Madrid ( n = 50) and the Basque Country ( n = 800).
Enrolment
Midwives and obstetricians give eligible participants oral information about the study and hand out an information package to the pregnant women in the 12th week. After the visit, all eligible pregnant women who visit the public health centre of each area have an interview with INMA staff to obtain additional information; they are then enrolled in the study. The inclusion criteria of the mothers are: (a) to belong to the study area (specific in each cohort), (b) to be at least 16 years old, (c) to have a singleton pregnancy, (d) to have their first prenatal visit (10-13 weeks of gesta-tion) in the main public hospital or health centre of the area, (e) to not have followed any programme of assisted reproduction, (f) to wish to deliver in the reference hospital, and (g) to have no communication problems. A characteristic of these areas is that a vast majority of the population attend the public health sector.
Informed consent
The study has been approved by the Ethical Committee of the Institut Municipal d'Investigacio Medica and by the Ethical Committees of the hospitals involved in the study. Pregnant women receive written and oral information about the study. Participants are asked for their written informed consent twice: once for their participation in the prenatal visits and the other time for the inclusion of their child into the follow-up study.
Data collection
A list of all assessments planned until the age of 4 years is shown in Tables 2 and 3. More detailed information on the INMA protocols is available upon request.
Information is collected using a variety of sources. Some general considerations about measurement tools are: questionnaires are administered in an interview format by trained interviewers; for biological samples, total blood, plasma and serum samples are divided in small aliquots and stored at − 80 ° C, urine and placentas are stored at − 20 ° C until delivery to the specialised laboratories. The amount of venous maternal blood to be taken is 20 mL at 12 weeks of gestation, 15 mL from the newborn (cord blood) and 10 mL at the age of 4 years. DNA will be extracted from blood with ethylenediamine tetraacetic acid (EDTA). A 100 mL urine sample is collected from the mother at 12 weeks' gestation and the child at the age of 4 years. A nail sample is collected from mothers at 12 weeks' gestation and from children at the age of 4 years. Hair samples will be obtained at birth and at the age of 4 years. Placentas will be collected from one out of five women. Breast milk (20 mL) will be taken at the end of the first feeding on the third day after delivery and will be stored at − 80 ° C.
Assessment of determinants (Table 2)
Air pollution:
• Questionnaire: assessment of the exposures to traffic and environmental tobacco smoke during pregnancy (28-32 weeks) and at the ages of 1 and 4 years through a questionnaire. • Questionnaires: water consumption during pregnancy and childhood using a questionnaire at 28-32 weeks of gestation and at the ages of 1 and 4 years. Measurement of the environment: thrihalomethanes and other disinfection by-products in water of a subsample of residences. Persistent and semi-persistent pollutants:
• Questionnaires: exposure during pregnancy and childhood using a questionnaire at 28-32 weeks of gestation and at the ages of 1 and 4 years.
• Biological samples: measurement of OCs, polybrominated diphenyl ethers, phthalates and phenols in maternal serum at 12 weeks of gestation, cord serum and child serum at the age of 4 years. Arsenic in maternal and child nails at the age of 4 years. Lead (in child serum) and methyl-mercury (in child hair) at birth and at the age of 4 years. Measurement of different endocrine disrupters with oestrogenic activity in placentas. Diet determinants:
• Questionnaires: maternal diet assessment by a food frequency questionnaire at two point interviews (10-13 and 28-32 weeks of gestation). Infant and child diet assessment by a breast-feeding questionnaire at the age of 1 year and a food frequency questionnaire at the age of 4 years.
• Biological samples: measurement of fatty acids, vitamins C and E, and folate in maternal serum, fatty acids in cord blood, vitamins E and C in breast milk, and measurement of fatty acids and vitamins at the age of 4 years. Other determinants:
• Oxidative stress (as underlying mechanism): measurement of lipid hydroperoxides in maternal serum (12 weeks' gestation) and F2 isoprostanes in urine at 12 and 32 weeks' gestation, and child urine at the age of 1 year.
• Questionnaires: sociodemographic data, relevant data about biological father, medical and obstetric history, family history of allergies, use of drugs and vaccinations during pregnancy, complications of the current pregnancy at 12 and 32 weeks of gestation.
• Genetic determinants: total blood will be stored to measure genetic determinants for the different outcomes in the future.
• Parental psychopathology: mental health of both parents and maternal and paternal attachment to the infant measured using a questionnaire at the age of 1 year.
Assessment of outcomes (Table 3)
Reproductive outcomes:
• Intrauterine growth measured by fetal biometry assessed longitudinally by ultrasound scans at 12, • Thyroid status: measurement of thyroid stimulating hormone (TSH) at birth, and of free-T4, TSH and total-T3 at the age of 4 years. Asthma and atopy:
• Measurement of specific IgE in maternal serum during pregnancy to assess maternal atopy.
• Assessment of asthma symptoms through questionnaire. Atopy: physical dermal examination at the age of 1 year and measurement of total IgE at the age of 4 years.
Data quality, control and management
The INMA field staff such as interviewers, laboratory technicians and project paediatricians have been specifically trained for the project. All measurements have been tested for inter-and intra-reproducibility.
An electronic database has been prepared to monitor the cohort in order to facilitate the follow-up and to minimise the loss to follow-up. Information regarding maternal identification, inclusion number, information required for the follow-up (such as enrolment date, date of last menstrual period or expected date of delivery), and the calendar for the visits and the sampling procedures is collected by the INMA staff. Some information is also gathered on refusals in order to compare basic sociodemographic characteristics between both groups.
Confidentiality is guaranteed by keeping the monitoring data file separated from the questionnaire information and the biological samples.
Communication
The INMA Study aims to guarantee helpful communication to the participants of the INMA by collective meetings and periodic bulletins, to communicate the results to the general population through the web page and other sources, to guarantee that INMA data are published in the scientific press, and to provide useful information to health professionals, health officers and politicians.
